background image

Mantle Cell Lymphoma Clinical Trials

Find clinical trials for mantle cell lymphoma. Search for mantle cell lymphoma clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting
Active & Responsive

A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

for
Mantle Cell Lymphoma (MCL)
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06788652

Recruiting
Active & Responsive

SynKIR-310 for Relapsed/Refractory B-NHL

for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: Denver CO, Atlanta GA, Fairway KS, New Brunswick NJ
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT06544265

Phase1, Recruiting
Active & Responsive

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

for
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma,
Location: Anchorage AK, Gilbert AZ, Phoenix AZ, Aurora CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05458297

Phase2, Recruiting
Active & Responsive

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Gilbert AZ, Phoenix AZ, La Jolla CA, Stanford CA,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA
Sponsor: Christine Ryan

Sex: All

Age: 18+

Code: NCT06854003

Phase2, Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Montreal
Sponsor: Iksuda Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT05365659

Phase1, Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

for
Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL),
Location: Duarte CA, Chicago IL, Rochester MN, Omaha NE,
Sponsor: MEI Pharma, Inc.

Sex: All

Age: 18+

Code: NCT03547115

Phase1, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, Denver CO, Chicago IL, Bethesda MD,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase2, Recruiting